Brom Rector

17: Ian McDonald & Gideon Shapiro of Bright Minds Bio ($DRUG). Is Psilocybin Dangerous? What is a 5HT2C Agonist? When will Bright Minds uplist to the NASDAQ?

Listen Later

🍄 Bright Minds Bio is a psychedelics research company focused on novel  psychedelics with shorter trip times and lower risk than traditional  psychedelics.  In this episode of The Integration Conversation, we  discuss the risk of traditional psychedelics, what a 5HT2C agonist is,  Bright Mind's NASDAQ Uplisting, and discuss why Bright Minds might be  undervalued relative to its peers.     


⭐️ Become an Integration Insider and get early access to episodes: 

https://patreon.com/theintegrationco  


🎧 Listen on Spotify and other podcast platforms:  

https://anchor.fm/theintegrationco  


🐦 brom on twitter:  

https://twitter.com/therealbrom  


🎇 Clips and other stuff on Instagram:  

https://instagram.com/theintegrationco  


💌 Email:   

[email protected]   


⏰ Timestamps:  

  • 10:00 - what are the issues with classic psychedelics?  
  • 14:30 - are psychedelics dangerous?  
  • 20:35 - what are 5-HT2C agonists? 
  • 24:45 - what is brightminds pipeline timeline? 
  • 27:00 - will bright mind's drugs require clinics? 
  • 30:00 - what does bright minds think about decriminalization?  
  • 37:30 - how will big pharma play psychedelics?  
  • 40:30 - Is Bright Minds undervalued?  
  • 42:00 - When will Bright Minds NASDAQ Uplist & what are upcoming catalysts? 
  • 46:00 - followup    


    • Disclaimer: This video is not financial advice. Brom holds shares in Bright Minds.

    ...more
    View all episodesView all episodes
    Download on the App Store
    Brom RectorBy Brom Rector and XEIA
    • 5
    • 5
    • 5
    • 5
    • 5

    5

    6 ratings

    More shows like Brom Rector

    View all
    Pivot by New York Magazine

    Pivot

    8,901 Listeners

    All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

    All-In with Chamath, Jason, Sacks & Friedberg

    8,778 Listeners